Senior insider sale
Chief Business Officer at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$2.23M
22.50K shares
What this filing means
GOODMAN NOAH plans to sell 22.50K shares of KYMERA THERAPEUTICS, INC. valued at approximately $2.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006765
Officer· Chief Business Officer
Since Mar 2026
22.50K
Shares to sell
$2.23M
Approx. market value
3.39K
Acquired (3 months)
1
Planned
6 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/8/2026
3.39KTotal acquired3.39K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/8/2026 | Restricted Stock Units N/A | 3.39K | — |
| Total | 3.39K | ||
Planned & Completed Dispositions7
Completed
—Completed
Units to sell
5K
Market value
$570.0K
6/25/2026
—Completed
Units to sell
2.50K
Market value
$247.5K
6/22/2026
—Completed
Units to sell
1.35K
Market value
$121.2K
4/14/2026
—Completed
Units to sell
2K
Market value
$174.7K
4/10/2026
—Completed
Units to sell
5.76K
Market value
$500.6K
4/9/2026
—Completed
Units to sell
2.50K
Market value
$222.5K
4/9/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.39K
Market value
$388.6K
7/1/2026
Total
Units
22.50K
Value
$2.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 5K | $570.0K | — | Completed |
6/22/2026 | 2.50K | $247.5K | — | Completed |
4/14/2026 | 1.35K | $121.2K | — | Completed |
4/10/2026 | 2K | $174.7K | — | Completed |
4/9/2026 | 5.76K | $500.6K | — | Completed |
4/9/2026 | 2.50K | $222.5K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 3.39K | $388.6K | NASDAQ | Planned |
| Total | 22.50K | $2.23M | ||